|
||
Original Article |
jchen{at}mit.edu
| Abstract |
|---|
|
|
|---|
faster upon restimulation. Like antigen-induced memory T cell differentiation, the homeostasis-driven process requires T cell proliferation and, initially, the presence of appropriate restricting major histocompatibility complexes, but it differs by occurring without effector cell formation and without requiring interleukin 2 or costimulation via CD28. These findings define repetitive cell division plus T cell receptor ligation as the basic requirements for naive to memory T cell differentiation.
Key Words: memory T cells developmental requirements TCR ligation proliferation homeostasis
We recently described a system for generating large numbers of memory CD8 T cells 10. In this system, naive CD8 T cells from 2C TCR transgenic mice on the recombination activating gene (RAG)-1–/– background (termed 2C/RAG mice) were transferred into syngeneic RAG-1–/– recipients lacking their own lymphocytes. The recipients were then immunized with a potent antigenic peptide. 1 mo or more after immunization, the surviving 2C cells expressed the cell surface markers and functional properties of memory CD8 T cells. Unexpectedly, however, we subsequently noted that transferred naive 2C T cells also developed into memory CD8 T cells even if the recipients were not immunized. The pursuit of this observation, presented here, shows that (a) homeostasis-mediated proliferation of naive T cells results in their differentiation into functional memory T cells, (b) this differentiation is dependent on T cell proliferation and initially, the presence of appropriate MHCs, and (c) this differentiation pathway from naive to memory cells occurs without forming effector cells and without requiring IL-2 or costimulation via CD28.
Adoptive Transfer.
Antibodies, Intracellular IFN-
Cytolytic Assays.
Tumor Rejection.
![]()
Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Naive T cells can be stimulated through their TCRs by cognate antigens to proliferate in normal mice 1. They also undergo homeostasis-driven proliferation in lymphopenic mice in the absence of overt antigen stimulation. Although administration of exogenous antigen is not needed, homeostasis-driven T cell proliferation requires the presence of appropriate restricting MHCs 23456, indicating that the engagement of TCR by endogenous peptide–MHC complexes is required. Antigen-stimulated T cell proliferation results in their expression of CD44 and differentiation into memory T cells. Proliferating T cells in lymphopenic individuals also display CD44 3789 and largely on this basis these cells are often ambiguously termed "activated/memory" cells. However, whether the resultant T cells following homeostasis-driven proliferation are true memory cells, i.e., are able to respond with enhanced intensity and speed to reencounter with the same antigen, has not been determined. Neither is the role of proliferation, whether induced by antigen or by homeostasis, clear in memory T cell development.
![]()
Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Mice.
The 2C TCR recognizes SIYRYYGL peptide in association with MHC class I Kb molecules 11. 2C TCR transgenic mice 12 were all on the RAG-1–deficient (RAG-1–/– 13) background and have been backcrossed onto C57BL/6 (B6) background for seven generations. RAG-1–/– mice, backcrossed with B6 mice for 13 generations, were used between 3 and 10 wk of age as adoptive transfer recipients. Naive 2C and B6 mice and B6 mice deficient in either IL-2 or CD28 (from The Jackson Laboratory) were used at 3–7 wk of age as donors. B6 mice expressing the green fluorescent protein (GFP) transgene (B6/GFP) were from Drs. M. Okabe and M. Yokoyama (Research Institute for Microbial Diseases, Osaka University, Suita, Japan; reference 14).
Different numbers of naive T cells from lymph nodes of 2C or B6 mice or FACS®-purified CD8+CD44– cells from these mice were injected intravenously into nonirradiated syngeneic (H-2b) RAG-1–/– recipients or syngeneic normal B6 recipients. 3 wk or more after the transfer, CD8 T cells from the nonimmunized recipients were analyzed. Antigen-induced memory 2C cells were generated by subcutaneously injecting some recipients of the 2C cells with 50 µg of the SIYRYYGL peptide in complete Freund's adjuvant and analyzing them 4 mo or more later. For analysis of cell division, lymph node cells from naive 2C or B6 mice were labeled with carboxyfluorescein diacetate-succinimidyl ester (CFSE) and then transferred into nonirradiated RAG-1–/– recipients. In addition, 2C cells and B6 T cells were activated in vitro with 10 nM SIYRYYGL peptide or plate-bound anti-CD3
plus anti-CD28 antibodies (10 µg/ml each), respectively, for 3 d before transfer into normal B6 recipients.
Staining, and Flow Cytometry.
Antibodies to CD8, CD25, CD69, CD44, CD62L (L-selectin), Ly-6C, and IL-2Rβ were purchased as conjugates from BD PharMingen. Anti-CD11A (LFA-1) antibody was conjugated with FITC. Clonotypic antibody 1B2, specific for the 2C TCR, was conjugated to biotin. Cells were stained in the presence of 3 µg/ml anti-FcR antibody in PBS containing 0.1% bovine serum albumin and 0.1% NaN3 and analyzed on a FACSCaliburTM, collecting 10,000–10,000,000 live cells per sample. To detect intracellular IFN-
, cells were incubated in the presence or absence of immobilized anti-CD3
antibody for 3 h. Then, brefeldin A was added and the cultures were incubated for another 5 h. The cells were then surface stained with antibody to CD8 before being fixed and stained for intracellular IFN-
.
Cells from lymph nodes and spleens were incubated with a cocktail of biotin-labeled antibodies to FcR, CD4, Mac-1, NK1.1, and B220, followed with streptavidin-labeled microbeads (Miltenyi Biotec), using 2 beads/cell, and purified on a SuperMACS cell sorter. Magnetically purified memory (85%) and naive (95%) CD8 T cells were used in CTL assays. 51Cr-labeled T2-Kb cells were used as target cells in a 6-h CTL assay because low E/T ratios were used (1:1 or 2.5:1). Except for sextuplet wells to determine spontaneous and maximum 51Cr release, all samples were assayed in triplicate. Specific lysis was calculated as: [(experimental counts – spontaneous counts)/(total counts – spontaneous counts)] x 100.
EL4 thymoma cells were transfected with an hsp65-P1 vector expressing mycobacterial heat shock protein 65 fused with a P1 peptide containing SIYRYYGL epitope 15. Transfectants were screened for their ability to serve as good targets for 2C CTL clones in cytolytic assays and a positive transfectant, called EL4-SYRGL, was used for implantation. B6 mice were implanted with 3 x 106 EL4 tumor cells on one flank and 3 x 106 EL4-SYRGL tumor cells on the opposite flank. 2 d later, mice were adoptively transferred with a graded number (1 x 104, 1 x 105, or 1 x 106) of naive 2C cells, or memory 2C cells from immunized mice, or memory 2C cells from nonimmunized mice. Tumor sizes were measured with a caliper at days 7, 10, and 16 after implantation.
![]()
Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Spontaneous Memory Cell Differentiation.
In contrast to freshly isolated naive 2C T cells, the persisting 2C T cells in nonimmunized recipients expressed the same elevated levels of CD44, Ly-6C, IL-2Rβ, and LFA-1 as memory 2C T cells from the immunized recipients (Fig. 1 a). They did not express IFN-
constitutively but could be induced to express this cytokine within 8 h of stimulation with anti-CD3
antibody (Fig. 1 b), and after 24 h stimulation almost all of these cells (>96%) were positive for IFN-
(data not shown). Memory cells from both nonimmunized and immunized recipients showed a similar dose–response profile in TCR downmodulation and CD69 expression, requiring
30-fold lower peptide concentration than naive cells to downmodulate the TCR level by 50% or to induce CD69 expression by
80% of the cells (Fig. 2 b). They also lysed target cells ex vivo in a peptide- and TCR-dependent manner (Fig. 2 a). In addition, memory cells from immunized and nonimmunized recipients rejected or suppressed the growth of EL4 tumor cells that expressed the SIYRYYGL epitope but not the parental tumor cells (control), whereas naive cells failed to suppress the growth of both types of tumor cells (Fig. 2 c). Thus, in these assays, memory 2C T cells arising in RAG-1–/– recipients were either the same or very similar phenotypically and functionally, whether or not the recipients were immunized with the exogenous antigenic peptide.
|
|
within 8 h of anti-CD3
stimulation (Fig. 1 b), and lysed target cells directly ex vivo in a ConA–based CTL assay (Fig. 2 a). Hence, the spontaneous differentiation of memory CD8 T cells after adoptive transfer of naive cells into syngeneic RAG-1–/– recipients is not unique to cells expressing a particular TCR: it is a general property associated with the adoptive transfer into lymphopenic recipients.
At the time of transfer, the majority of CD8 T cells from both the 2C transgenic and normal B6 donors were naive as indicated by the absence or only low levels of cell surface CD44 and Ly-6C, minimal IFN-
expression, and negligible levels of cytolytic activity (Fig. 1 and Fig. 2). Nevertheless, the spontaneously derived memory T cells in the RAG-1–/– recipients could have resulted from a preferential expansion of a few memory T cells 7 in the transferred cell population. To exclude this possibility, CD8+CD44– cells were purified from 2C/RAG mice (99.9% CD44–) and B6 mice (99.8% CD44–) and then transferred into RAG-1–/– recipients. Within 3 wk of transfer, the purified naive cells had acquired the characteristic surface phenotype of memory cells and could be rapidly induced to express IFN-
(Fig. 1, a and b). Moreover, when equal numbers of naive or memory 2C cells were added to a fixed number of lymph node cells from naive B6 mice and the mixtures were transferred into RAG-1–/– recipients, after 60 d the ratio of 2C cells (distinguished by a clonotypic antibody to the 2C TCR) to B6 CD8 T cells was the same whether the 2C cells added were naive or memory phenotype (data not shown). These findings show that the memory CD8 T cells arising in nonimmunized RAG-1–/– recipients are not the result of selective expansion of a few memory T cells present in the transferred inoculum, but indeed are derived from transferred naive cells in the absence of exogenous antigen.
Progressive Acquisition of Memory Phenotype.
To examine the kinetics of the spontaneous memory CD8 T cell differentiation, 1 x 105 naive 2C cells were transferred into RAG-1–/– recipients and the number of surviving 2C cells and their CD44 expression were monitored at different times. As shown in Fig. 3 a, the number of 2C T cells in the spleen and lymph nodes and their levels of CD44 expression increased progressively over time. 40 d after transfer, more T cells were recovered from spleen and lymph nodes than had been initially transferred, indicating that the transferred T cells had proliferated in the recipients. To demonstrate the proliferation more directly, cells were labeled with CFSE and then transferred into syngeneic recipients. When a cell divides, the intensity of CFSE fluorescence decreases by about half and therefore provides an accurate count of the number of cell divisions 16. When 2.5 x 105 CFSE-labeled cells were transferred, within 5 d >90% of the cells divided and the median number of divisions was 2.5 (Fig. 2 b). In contrast, when 40 times more cells (1.1 x 107) were transferred, fewer cells (
65%) divided and the median number of divisions was 1 during the same period. Furthermore, when 2.5 x 105 cells were transferred into syngeneic B6 recipients having normal levels of T cells, <20% of the cells divided. Similarly, most of the newly transferred CFSE-labeled naive 2C cells did not divide in RAG-1–/– recipients that had previously received naive 2C cells and been immunized with peptide ("filled" with memory cells). Thus, the extent of proliferation was greater when fewer cells were transferred and depended on the recipients' status as "empty" or "filled," characteristics of homeostasis-mediated proliferation.
|
after anti-CD3
stimulation. As shown in Fig. 3 c, when increasing numbers of cells were transferred (1 x 105, 1 x 106, 1 x 107, and 2.5 x 107), progressively smaller proportions of persisting T cells expressed IFN-
or became CD44high. Thus, the spontaneous transition of naive to memory CD8 T cells appears to be directly linked to the extent of homeostasis-mediated proliferation.
The direct coupling of IFN-
expression with cell proliferation was shown by transferring CFSE-labeled lymph node cells from 2C or B6 donors into RAG-1–/– recipients and assaying for IFN-
and CD44 expression as a function of the number of cell divisions. 9 d after transfer, lymph node cells from the recipients were incubated in vitro in the presence or absence of anti-CD3
antibody for 8 h and then assayed for intracellular IFN-
expression. Very few CD8 T cells from recipients of either 2C or B6 donors expressed IFN-
in the absence of anti-CD3
stimulation, but many of them expressed IFN-
within 8 h of stimulation (Fig. 4 a). The proportion of IFN-
–positive cells increased linearly in relation to the number of cell divisions, indicating that a relatively constant proportion of the dividing cells acquires the capacity for rapid induction of IFN-
expression at each cell division.
|
(Fig. 4 b). In contrast, the T cell activation markers CD69 and CD25 (the IL-2 receptor
chain), which are known to be induced on antigen-activated effector T cells, were not detected on transferred CD8 T cells after any number of cell divisions (Fig. 4 c, and data not shown). Similarly, CD69 and CD25 expression were not detected on T cells on days 12 and 15 when they have undergone nine or more divisions (data not shown). Together with data showing that proliferating T cells in nonimmunized RAG-1–/– recipients did not express IFN-
unless stimulated by anti-CD3
, these findings suggest that effector cells are not formed when homeostasis drives naive T cells to differentiate into memory T cells.
To examine more closely whether effector cells can be generated and detected in our transfer system, 2 d after the transfer of CFSE-labeled 2C T cells, RAG-1–/– recipients were immunized with a potent agonist peptide specific for the 2C TCR. 3 d later, 2C cells from lymph nodes of the immunized recipients were assayed directly for IFN-
, CD44, and CD25 expression. Most of these antigen-stimulated cells behaved as effector cells: 80% expressed IFN-
constitutively and 20% were positive for CD25 (Fig. 4d and Fig. e). Cell division after antigen stimulation also occurred much faster than homeostasis-mediated cell division, e.g., approximately eight divisions (peak frequency) in 3 d compared with four divisions in 9 d, respectively. These results further support the notion that naive CD8 T cells can directly differentiate into memory cells during homeostasis-driven proliferation without first becoming activated effector cells whereas effector cells are prominent in the course of antigen-induced memory T cell differentiation 1718.
Requirement for Proliferation for Memory T Cell Differentiation.
Although our findings clearly show that the spontaneous transition from naive to memory CD8 T cells progressively occurs in parallel with cell proliferation, it was not clear that cell division was actually essential. To address this issue, we transferred lymph node cells from 2C donors or B6 donors that expressed the GFP transgene (B6/GFP) into syngeneic normal B6 recipients. The transferred T cells did not appreciably proliferate in the normal recipients (Fig. 3) and 40 d later, the CD44 expression profile of the surviving T cells from both 2C and B6/GFP donors resembled that of the respective naive donor cells (Fig. 5). If, however, 2C or B6 CD8 T cells were activated through their TCR and allowed to proliferate for 3 d in vitro before being transferred into normal B6 recipients, the surviving cells showed higher levels of CD44 expression, typical of memory T cells. Thus, the mere survival of transferred T cells in the recipients is not sufficient for their differentiation into memory T cells. Proliferation is required.
|
|
| Discussion |
|---|
|
|
|---|
Besides TCR ligation, we show that homeostasis-driven memory T cell differentiation is directly coupled to cell proliferation. Consistent with the requirement for proliferation, CD8 T cells bearing TCR-specific for the H-Y male antigen do not proliferate in syngeneic lymphopenic females 34820 and do not differentiate into memory cells 17. Since lymphocyte proliferation is an invariable response to antigen stimulation, proliferation is also likely to be required for antigen-induced memory T cell differentiation 1721. Unlike antigen-induced memory T cell differentiation, however, homeostasis-driven memory cell differentiation does not require (a) formation of activated effector cells, (b) administration of exogenous antigen, or (c) costimulatory CD28 molecules and cytokine IL-2. Thus, the two basic requirements for both antigen-induced and homeostasis-driven differentiation of naive to memory T cells are TCR ligation and repetitive cell division.
Why is proliferation so essential for memory T cell differentiation? One of the hallmarks distinguishing naive from memory CD8 T cells is the speed with which IFN-
expression is induced after TCR ligation. In naive T cells, activation of IFN-
expression is much slower because the IFN-
locus has first to be relieved of epigenetic repression 222324. That the IFN-
gene is poised for rapid expression in memory cells suggests that the chromatin structure of this locus is remodeled during the transition from naive to memory cells 252627. The requirement for proliferation for memory T cell differentiation is in accord with evidence that DNA replication facilitates chromatin remodeling 2829. Taken together, these diverse observations suggest that while signals from TCR ligation act selectively on the regulation of genes whose expression characterizes memory T cells, DNA replication (proliferation) facilitates the chromatin remodeling that allows these gene alterations to persist. The resulting epigenetic changes could then account for the stability of the memory T cells' phenotype over periods approaching an animal's lifetime.
Several different pathways have been proposed for memory T cell development 173031. Our findings demonstrate that during homeostasis-driven memory T cell differentiation, naive CD8 T cells can directly differentiate into memory cells without first becoming activated effector cells (Fig. 3). Consistent with this finding, a recent study in which memory CD8 T cells were monitored in vivo after viral infection suggests that a small fraction of antigen-activated T cells appears to commit to becoming memory T cells too soon to have arisen from effector cell precursors 32. The development of memory and effector T cells thus parallels the distinct developmental pathways by which memory B cells and antibody-secreting (effector) B cells develop 30.
Finally, although homeostasis-driven memory cell differentiation probably does not occur in immunocompetent individuals, it seems to be involved in some pathologic conditions and may explain why lymphopenic individuals, including AIDS patients and bone marrow transplant recipients, are at greater risk of developing some autoimmune diseases 33343536. Autoreactive memory cells, generated via homeostasis-driven proliferation in these individuals, would require relatively little antigen for reactivation and are thus more likely than naive cells to promote the development of autoimmune diseases.
| Acknowledgments |
|---|
assay; Dr. D. Palliser for assistance with the tumor rejection experiment; Drs. M. Okabe and M. Yokoyama for B6/GFP mice; members of the Chen and Eisen laboratories for helpful discussions; and Dr. P. Sharp for critical reading of the manuscript. This work was supported in part by grants from the National Institutes of Health grants AI-44478 (to J. Chen) and AI-44477 and CA-60686 (to H.N. Eisen).
Submitted: 29 February 2000
Revised: 4 May 2000
Accepted: 6 June 2000
B.K. Cho's present address is Medical Scholars Program and Department of Biochemistry, University of Illinois, Urbana, IL 61801.
| References |
|---|
|
|
|---|
Goldrath A.W. & Bevan M.J.. Selecting and maintaining a diverse T-cell repertoire, Nature., 402, 1999, 255–261.[Medline]
Tanchot C., Lemonnier F.A., Pérarnau B., Freitas A.A. & Rocha B.. Differential requirements for survival and proliferation of CD8 naive or memory T cells, Science., 276, 1997, 2057–2062.
Viret C., Wong F.S. & Janeway C.A. Jr.. Designing and maintaining the mature TCR repertoirethe continuum of self-peptide:self-MHC complex recognition, Immunity., 10, 1999, 559–568.[Medline]
Ernst B., Lee D.-S., Chang J.M., Sprent J. & Surh C.D.. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery, Immunity., 11, 1999, 173–181.[Medline]
Bender J., Mitchell T., Kappler J. & Marrack P.. CD4+ T cell division in irradiated mice requires peptides distinct from those responsible for thymic selection, J. Exp. Med., 190, 1999, 367–373.
Goldrath A.W. & Bevan M.J.. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts, Immunity., 11, 1999, 183–190.[Medline]
Tanchot C. & Rocha B.. The peripheral T cell repertoireindependent homeostatic regulation of virgin and activated CD8+ T cell pools, Eur. J. Immunol., 25, 1995, 2127–2136.[Medline]
Oehen S. & Brduscha-Reim K.. Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipientsa pitfall for T cell memory studies?, Eur. J. Immunol., 29, 1999, 608–614.[Medline]
Kieper W.C. & Jameson S.C.. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands, Proc. Natl. Acad. Sci. USA., 96, 1999, 13306–13311.
Cho B.K., Wang C., Sugawa S., Eisen H.N. & Chen J.. Functional differences between memory and naive CD8 T cells, Proc. Natl. Acad. Sci. USA., 96, 1999, 2976–2981.
Udaka K., Wiesmuller K.H., Kienle S., Jung G. & Walden P.. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone, J. Immunol., 157, 1996, 670–678.[Abstract]
Sha W.C., Nelson C.A., Newberry R.D., Kranz D.M., Russell J.H. & Loh D.Y.. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice, Nature., 335, 1988, 271–274.[Medline]
Mombaerts P., Iacomini J., Johnson R.S., Kerrup K., Tonegawa S. & Papioannou V.E.. RAG-1-deficient mice have no mature B and T lymphocytes, Cell., 68, 1992, 869–877.[Medline]
Okabe M., Ikawa M., Kominami K., Nakanishi T. & Nishimune Y.. Green mice as a source of ubiquitous green cells, FEBS Lett., 407, 1997, 313–319.[Medline]
Cho B., Palliser D., Guillen E., Wisniewski J., Young R.A., Chen J. & Eisen H.N.. A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins, Immunity., 12, 2000, 1–20.[Medline]
Lyons A.B. & Parish C.R.. Determination of lymphocyte division by flow cytometry, J. Immunol. Methods., 171, 1994, 131–137.[Medline]
Opferman J.T., Ober B.T. & Ashton-Rickardt P.G.. Linear differentiation of cytotoxic effectors into memory T lymphocytes, Science., 283, 1999, 1745–1748.
Swain S., Hu H. & Huston G.. Class II-independent generation of CD4 memory T cells from effectors, Science., 286, 1999, 1381–1383.
Murali-Krishna K., Lau L.L., Sambhara S., Lemonnier F., Altman J. & Ahmed R.. Persistence of memory CD8 T cells in MHC class I-deficient mice, Science., 286, 1999, 1377–1381.
Bruno L., Kirberg J. & von Boehmer H.. On the cellular basis of immunological T cell memory, Immunity., 2, 1995, 37–43.[Medline]
Hou S., Hyland L., Ryan K.W., Portner A. & Doherty P.C.. Virus-specific CD8+ T-cell memory determined by clonal burst size, Nature., 369, 1994, 652–654.[Medline]
Gett A.V. & Hodgkin P.D.. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation, Proc. Natl. Acad. Sci. USA., 95, 1998, 9488–9493.
Bird J.J., Brown D.R., Mullen A.C., Moskowitz N.H., Malhowald M.A., Sider J.R., Gajewski T.F., Wang C.R. & Reiner S.L.. Helper T cell differentiation is controlled by the cell cycle, Immunity., 9, 1998, 229–237.[Medline]
Richter A., Lohning M. & Radbruch A.. Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression, J. Exp. Med., 190, 1999, 1439–1450.
Fitzpatrick D.R., Shirley K.M., McDonald L.E., Bielefeldt-Ohmann H., Kay G.E. & Kelso A.. Distinct methylation of the interferon
(IFN-
) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytesregional IFN-
promoter demethylation and mRNA expression are heritable in CD44highCD8+ T cells, J. Exp. Med., 188, 1998, 103–117.
Fitzpatrick D.R., Shirley K.M. & Kelso A.. Stable epigenetic inheritance of regional IFN-
promoter demethylation in CD44highCD8+ T lymphocytes, J. Immunol., 162, 1999, 5053–5057.
Agarwal S. & Rao A.. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation, Immunity., 9, 1998, 765–775.[Medline]
Weintraub H., Flint S.J., Leffak I.M., Groudine M. & Grainger R.M.. The generation and propagation of variegated chromosome structures, Cold Spring Harbor Symp. Quant. Biol., 42, 1978, 401–407.
Shibahara K.-I. & Stillman B.. Replication-dependent marking of DNA by PCNA facilitates CAF-1-coupled inheritance of chromatin, Cell., 96, 1999, 575–585.[Medline]
Ahmed R. & Gray D.. Immunologic memory and protective immunityunderstanding their relation, Science., 272, 1996, 54–60.[Abstract]
Oehen S. & Brduscha-Reim K.. Differentiation of naive CTL to effector and memory CTLcorrelation of effector function with phenotype and cell division, J. Immunol., 161, 1998, 5338–5346.
Jacob J. & Baltimore D.. Modelling T-cell memory by genetic marking of memory T cells in vivo, Nature., 399, 1999, 593–597.[Medline]
Gleeson P.A., Toh B.H. & van Driel I.R.. Organ-specific autoimmunity induced by lymphopenia, Immunol. Rev., 149, 1996, 97–125.[Medline]
Sleasman J.W.. The association between immunodeficiency and the development of autoimmune disease, Adv. Dent. Res., 10, 1996, 57–61.
Sherer Y. & Shoenfeld Y.. Autoimmune diseases and autoimmunity post-bone marrow transplantation, Bone Marrow Transplant., 22, 1998, 873–881.[Medline]
Williams D.I., Williams D.J., Williams I.G., Unwin R.J., Griffiths M.H. & Miller R.F.. Presentation, pathology, and outcome of HIV associated renal disease in a specialist center for HIV/AIDS, Sex Transm. Infect., 74, 1998, 179–184.[Abstract]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|